CG Oncology Inc
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
From time to time, our Section 16 officers (as defined in Rule 16a–1(f)) and directors may enter into Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K) for the purchase or sale of our securities. During the three months ended September 30, 2024, our Section 16 officers and directors adopted or terminated contracts, instructions or written plans for the purchase or sale of our securities as noted in the table below.
| Trading Arrangement | |||||
|---|---|---|---|---|---|
| Section 16 Officer or Director · Action · Date · Rule 10b5-1* · Non-Rule 10b5-1** · Total Shares to Be Sold · Expiration Date | |||||
| Leonard Post, PhD | Adoption | September 6, 2024 | X | 23,000 | The earlier to occur of (i) November 28, 2025, and (ii) upon the execution of all instructions provided in the plan |
| Charming Jade Limited*** | Adoption | September 13, 2024 | X | 1,266,814 | The earlier to occur of (i) June 11, 2025, and (ii) the execution of all instructions provided in the plan |
*Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
**“Non-Rule 10b5-1 trading arrangement” as defined in item 408(c) of Regulation S-K under the Exchange Act.
*** Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc. Each of ORI Capital Holding Inc. and ORI Holding II Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Hong Fang Song, who serves on our Board of Directors, is the sole owner of Healthcare Seed Limited.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.